Anterogencoltd Stock Shares Outstanding
065660 Stock | KRW 19,560 230.00 1.16% |
AnterogenCoLtd fundamentals help investors to digest information that contributes to AnterogenCoLtd's financial success or failures. It also enables traders to predict the movement of AnterogenCoLtd Stock. The fundamental analysis module provides a way to measure AnterogenCoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AnterogenCoLtd stock.
AnterogenCoLtd |
AnterogenCoLtd Company Shares Outstanding Analysis
AnterogenCoLtd's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AnterogenCoLtd Shares Outstanding | 7.95 M |
Most of AnterogenCoLtd's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AnterogenCoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Based on the latest financial disclosure, AnterogenCoLtd has 7.95 M of shares currently outstending. This is 95.59% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The shares outstanding for all Republic of Korea stocks is 98.61% higher than that of the company.
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
All Next | Launch Module |
AnterogenCoLtd Fundamentals
Return On Equity | -5.92 | |||
Return On Asset | -0.0231 | |||
Profit Margin | (1.32) % | |||
Operating Margin | (0.77) % | |||
Current Valuation | 836.51 B | |||
Shares Outstanding | 7.95 M | |||
Shares Owned By Insiders | 21.02 % | |||
Shares Owned By Institutions | 5.63 % | |||
Price To Sales | 103.53 X | |||
Revenue | 8.12 B | |||
Gross Profit | 1.72 B | |||
EBITDA | (2.96 B) | |||
Net Income | (553.98 M) | |||
Cash And Equivalents | 6.97 B | |||
Debt To Equity | 43.70 % | |||
Current Ratio | 3.83 X | |||
Cash Flow From Operations | (3.05 B) | |||
Beta | 0.37 | |||
Market Capitalization | 108.41 B | |||
Total Asset | 136.7 B | |||
Net Asset | 136.7 B |
About AnterogenCoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AnterogenCoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AnterogenCoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AnterogenCoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in AnterogenCoLtd Stock
AnterogenCoLtd financial ratios help investors to determine whether AnterogenCoLtd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnterogenCoLtd with respect to the benefits of owning AnterogenCoLtd security.